Glassman Wealth Services Bristol Myers Squibb CO Transaction History

Glassman Wealth Services

$542 Million
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $14,059 - $16,776	-290 Reduced 11.32%	2,271 $116,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $519,910 - $581,340	-8,981 Reduced 77.81%	2,561 $148,000
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $572,115 - $635,245	8,980 Added 350.51%	11,542 $738,000
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $37,980 - $43,078	-578 Reduced 18.41%	2,562 $177,000
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $18,489 - $21,894	270 Added 9.41%	3,140 $225,000
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $19 - $11,526	150 Added 5.51%	2,870 $204,000
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $11,038 - $12,156	152 Added 5.92%	2,720 $209,000
Q1 2022 Aug 23, 2022	BUY	$61.48 - $73.72 $13,648 - $16,365	222 Added 9.46%	2,568 $188,000
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $16,538 - $19,830	269 Added 12.95%	2,346 $171,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $10,618 - $12,378	198 Added 10.54%	2,077 $130,000
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $10,828 - $12,683	183 Added 10.79%	1,879 $111,000
Q2 2021 Aug 04, 2021	SELL	$61.91 - $67.42 $2,043 - $2,224	-33 Reduced 1.91%	1,696 $113,000
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $6,705 - $7,541	113 Added 6.99%	1,729 $109,000
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $6,120 - $6,935	106 Added 7.02%	1,616 $100,000
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $11,371 - $12,600	-198 Reduced 11.59%	1,510 $91,000
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $47,857 - $55,950	-873 Reduced 33.82%	1,708 $100,000
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $25,148 - $36,547	542 Added 26.58%	2,581 $144,000
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $79,228 - $103,345	1,610 Added 375.29%	2,039 $131,000
Q3 2019 Nov 01, 2019	BUY	$42.77 - $50.71 $2,608 - $3,093	61 Added 16.58%	429 $22,000
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $178 - $197	4 Added 1.1%	368 $17,000
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $13,265 - $15,817	294 Added 420.0%	364 $17,000
Q4 2018 Feb 06, 2019	SELL	$48.76 - $63.23 $1,462 - $1,896	-30 Reduced 30.0%	70 $4,000
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $2,627 - $3,274	52 Added 108.33%	100 $6,000
Q4 2017 Feb 06, 2018	BUY	$59.94 - $65.35 $2,217 - $2,417	37 Added 336.36%	48 $3,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $441 - $509	8 Added 266.67%	11 $1,000
Q2 2017 Aug 09, 2017	BUY	N/A	3	3 $0

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account